Neumora Therapeutics, Inc. (NMRA) stock
Close on Nov 13, 2026Market cap $80.59MP/E –Yield –
Neumora Therapeutics statistics
64 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Q3 FY2026, expected soon
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.81
- 2.22
Share statisticsIndustry
- Shares Change (YoY)
- 8.04%
- 10.8%
- Float
- 145M
- 49M
- Shares Held by Insiders
- 22.8%
- 11.7%
- Shares Held by Institutions
- 40.4%
- 56.4%
Short sellingIndustry
- Short Interest
- 7M
- –
- Short Interest Change
- 24.2%
- -0.80%
- Short % of Float
- 4.83%
- 9.01%
- Short % of Shares Outstanding
- 3.73%
- 6.30%
- Days to Cover
- 5.12
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $3.65
- –
- 52-Week Low
- $0.32
- –
- 20-Day Moving Average
- $0.45
- –
- 50-Day Moving Average
- $0.60
- –
- 200-Day Moving Average
- $1.70
- –
- Average True Range (14)
- $0.07
- –
- Price Change (1 Week)
- -14.8%
- -1.15%
- Price Change (1 Month)
- 0.44%
- -4.87%
- Price Change (3 Months)
- -71.8%
- -21.0%
- Price Change (6 Months)
- -76.7%
- -20.6%
- Price Change (YTD)
- -76.0%
- -23.6%
- Price Change (1 Year)
- -85.0%
- -22.4%
- Price Change (3 Years)
- -96.4%
- -29.5%
- Average Volume (10 Days)
- 2M
- –
- Average Volume (20 Days)
- 2M
- –
- Average Volume (90 Days)
- 1M
- –
- Relative Volume
- 0.41
- 0.70
- Relative Strength Index (14)
- 40.9
- 43.4
- Volatility (1 Year)
- 130.7%
- 80.1%
- Beta (5 Years)
- 1.79
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -187.1%
- -49.9%
- Return on Assets (ROA)
- -121.9%
- -40.6%
- Return on Invested Capital (ROIC)
- -736.1%
- -32.9%
- Return on Capital Employed (ROCE)
- -216.7%
- -37.9%
Financial positionIndustry
- Current Ratio
- 4.50
- 3.30
- Quick Ratio
- 4.21
- 2.39
- Debt / Equity
- 2.54
- 0.49
- Interest Coverage
- -47.62
- -6.35
EfficiencyIndustry
- Profits Per Employee
- -$2.22M
- -$689.41K
- Employee Count
- 96
- 74
- WACC
- 8.21%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$212.72M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $3.92M
- $17.76M
- Net Cash Per Share
- $0.02
- $0.80
- Equity (Book Value)
- $44.52M
- $53.89M
- Book Value Per Share
- $0.24
- $1.50
- Tangible Book Value
- $44.52M
- $27.13M
- Working Capital
- $97.10M
- $79.99M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -264.0%
- -21.8%
Taxes and interestIndustry
- Interest Expense
- $4.44M
- $2.90M
- Income Tax
- $30.00K
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- -18.35
- 0.23
- Piotroski F-Score
- 0
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | NMRA | S&P 500 | Difference | NMRA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +15.9% | -3.0% | +18.9 pts | ||
| 3 months | -75.2% | -2.8% | −72.4 pts | ||
| Year to date | -76.0% | +11.5% | −87.5 pts | ||
| 1 year | -84.1% | +13.5% | −97.5 pts | ||
| 3 years | -96.4% | +77.7% | −174.1 pts | -67.0% | +21.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
7M NMRA shares were sold short on Oct 30, 2026, up 24.2% from the previous report, or 4.83% of the shares available to trade. At recent volumes it would take 5.1 days to buy them back. Over the last 20 sessions, 55.5% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 7,006,355 | +24.2% | 1,368,708 | 5.1 |
| Oct 15, 2026 | 5,639,597 | -15.7% | 2,434,731 | 2.3 |
| Sep 30, 2026 | 6,692,034 | -4.1% | 2,491,344 | 2.7 |
| Sep 15, 2026 | 6,979,674 | -13.1% | 773,503 | 9.0 |
| Aug 31, 2026 | 8,027,660 | +0.5% | 788,846 | 10.2 |
| Aug 14, 2026 | 7,991,116 | +4.8% | 596,204 | 13.4 |
| Jul 31, 2026 | 7,622,548 | -2.1% | 692,473 | 11.0 |
| Jul 15, 2026 | 7,786,397 | +16.5% | 1,029,524 | 7.6 |
| Jun 30, 2026 | 6,682,749 | +35.9% | 6,013,588 | 1.1 |
| Jun 15, 2026 | 4,917,298 | -11.9% | 2,262,846 | 2.2 |
| May 29, 2026 | 5,581,263 | +14.0% | 1,109,768 | 5.0 |
| May 15, 2026 | 4,897,401 | +6.4% | 1,648,146 | 3.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?